These findings suggest that decreased GPX4 protein levels may play an important role in decreasing liver cell resistance to ferroptosis, thereby inducing hepatocyte ferroptosis and promoting NAFLD progression. Here, GPX4 is linked to metabolic dysfunction-associated steatotic liver disease.